Role of osteocalcin in the calcium metabolism disorder
骨钙素在钙代谢紊乱中的作用
基本信息
- 批准号:05454505
- 负责人:
- 金额:$ 4.22万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for General Scientific Research (B)
- 财政年份:1993
- 资助国家:日本
- 起止时间:1993 至 1994
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Calcium homeostasis is controlled by the interactions of parathyroid-hormone, calcitonin and 1.25(OH)2D3. As a result, the blood calcium level is maintained about 10mg% in vivo. In addition to those hormones, several endogenous factors (glucocorticoid, gastrin, histamine, CGRP) also have been reported to have hypocalcemic potency and a number of agents have been used for the treatment of malignancy-induced hypercalcemia both clinically and in animal experiments. Several drugs acting on the central nerveous system can produce hypocalcemia in experimental animals, too. Aspirin has been treated as the most frequently used analgesic-antiinflammatory agent. We examined in detail the aspirin-induced hypocalcemia under many pathophysiological conditions (fasting, thyroparathyroid-ectomy, adrenalectomy, etc. We've thought that the mechanism of action would be induced by not the inhibition of calcium absorption from the intestinal tract but the functional disorder of bone lining cells. Osteocalcin (OC) is the bone proper organic matrix made by osteoblast. We tried to determine OC and OC segment in blood. Now we can do it by our method. In addition to it, we tried to detect the ionized calcium in blood. We took the blood sample by the orbital puncture under ether anethesia. In this step, we've known that ether anesthesia affects the ionized calcium level, especially under the heavy anesthetic condition. During the experiment, we could established many useful methods to use for further experiments. More works are necessary, however, to see the role of OC on the bone metabolism.
钙稳态由甲状旁腺激素、降钙素和 1.25(OH)2D3 的相互作用控制。从而使体内血钙水平维持在10mg%左右。除这些激素外,据报道,几种内源性因子(糖皮质激素、胃泌素、组胺、降钙素基因相关肽)也具有降钙功效,并且许多药物已在临床和动物实验中用于治疗恶性肿瘤引起的高钙血症。一些作用于中枢神经系统的药物也会在实验动物中引起低钙血症。阿司匹林已被视为最常用的镇痛抗炎药。我们详细研究了多种病理生理条件(禁食、甲状腺甲状旁腺切除术、肾上腺切除术等)下阿司匹林引起的低钙血症。我们认为,其作用机制不是通过抑制肠道钙吸收,而是通过骨衬细胞的功能障碍引起的。骨钙素(OC)是骨固有的有机基质,由骨钙素(OC)组成。 成骨细胞。我们试图确定血液中的 OC 和 OC 片段。现在我们可以用我们的方法来做。除此之外,我们还尝试检测血液中的离子钙。我们在乙醚麻醉下通过眼眶穿刺采集血样。在这一步中,我们知道乙醚麻醉会影响离子钙水平,特别是在重度麻醉条件下。在实验过程中,我们可以建立许多有用的方法来用于 进一步的实验。然而,还需要更多的工作来了解 OC 对骨代谢的作用。
项目成果
期刊论文数量(52)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Kobayashi Y.: "Comparison of mineralized tissue formation in young and aged rats." Jpn. J.Oral Biol.36. 187-193 (1994)
Kobayashi Y.:“年轻和老年大鼠矿化组织形成的比较。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Mataki S.: "Pharmacological Application to the Study of the Formation and the Resorption Mechanism of Hard Tissues" Ishiyaku EuroAmerica, Inc., Tokyo, 133-141 (1994)
Mataki S.:“硬组织形成和吸收机制研究的药理学应用”Ishiyaku EuroAmerica, Inc.,东京,133-141 (1994)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Mataki S.: "Significsance of osteocalcin in bone metabolism. In : Pharmacological Apporoach to the Study of the Formation and Resorption Mechanism of Hard Tissue. (Ogura H., ed.)" Ishiyaku Auro-America, Inc., Tokyo. 133-141 (1994)
Mataki S.:“骨钙素在骨代谢中的意义。见:硬组织形成和吸收机制研究的药理学方法。(Ogura H.,编辑)”Ishiyaku Auro-America,Inc.,东京。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
小林 泰浩: "オステオカルシン断片化に関する基礎的研究" 歯科基礎医学会雑誌. 36. 200 (1994)
小林泰宏:“骨钙素碎裂的基础研究”日本基础牙科医学会杂志 36. 200 (1994)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
俣木 志朗: "骨吸収時に出現する断片化Osteocalcinの分子種固定に関する基礎的研究" 日本骨代謝学会雑誌. 12. 221 (1994)
Shiro Matagi:“骨吸收过程中出现的碎片骨钙蛋白分子种类固定的基础研究”日本骨代谢学会杂志 12. 221 (1994)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KATO Yuzo其他文献
KATO Yuzo的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KATO Yuzo', 18)}}的其他基金
On the custom of real estimate's transaction in the concessions and the settlements of modern China
论近代中国租界和聚落中的实价交易习惯
- 批准号:
20730010 - 财政年份:2008
- 资助金额:
$ 4.22万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Study of the correlation bone in osteoclast resorption with atopic disease
破骨细胞吸收与特应性疾病相关性骨的研究
- 批准号:
15390563 - 财政年份:2003
- 资助金额:
$ 4.22万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Design and application of new fluoroescent substrate against membrane-bound processing enzyme
新型膜结合酶荧光底物的设计及应用
- 批准号:
11557138 - 财政年份:1999
- 资助金额:
$ 4.22万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Roles of metalloprotease-disintegrins in osteoclastogenesis
金属蛋白酶解整合素在破骨细胞生成中的作用
- 批准号:
09470404 - 财政年份:1997
- 资助金额:
$ 4.22万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Roles of lysosomal proteinases in the patho-physiological changes of hard tissues.
溶酶体蛋白酶在硬组织病理生理变化中的作用。
- 批准号:
62480381 - 财政年份:1987
- 资助金额:
$ 4.22万 - 项目类别:
Grant-in-Aid for General Scientific Research (B)
相似国自然基金
胃癌致骨丢失通过原纤毛蛋白IFT80与CCSAP相互作用抑制osteocalcin基因转录
- 批准号:n/a
- 批准年份:2022
- 资助金额:0.0 万元
- 项目类别:省市级项目
Osteocalcin/MiR-133a参与维生素K"促分化、抗凋亡"机制及其在预防激素型股骨头坏死中的作用
- 批准号:81301572
- 批准年份:2013
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Studies on the effect of maternal uncarboxylated osteocalcin on the metabolic properties of next generation
母体非羧化骨钙素对下一代代谢特性影响的研究
- 批准号:
20H03854 - 财政年份:2020
- 资助金额:
$ 4.22万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Cross-talk mechanism between muscle-derived irisin and bone-derived osteocalcin for robust skeletal construction in poultry.
肌肉源性鸢尾素和骨源性骨钙素之间的串扰机制,用于家禽强健的骨骼结构。
- 批准号:
20K06361 - 财政年份:2020
- 资助金额:
$ 4.22万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Is decreased levels of serum osteocalcin associated with increased risk of type 2 diabetes mellitus and atherosclerosis? - A 10-year follow-up study -
血清骨钙素水平降低是否与 2 型糖尿病和动脉粥样硬化风险增加相关?
- 批准号:
20K10516 - 财政年份:2020
- 资助金额:
$ 4.22万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The osteocalcin signaling pathway in exercise-induced improvements of brain function
运动引起的脑功能改善中的骨钙素信号通路
- 批准号:
428924 - 财政年份:2019
- 资助金额:
$ 4.22万 - 项目类别:
Studentship Programs
Neurocognitive effects of osteocalcin in type 2 diabetes
骨钙素对 2 型糖尿病的神经认知作用
- 批准号:
380359 - 财政年份:2018
- 资助金额:
$ 4.22万 - 项目类别:
Operating Grants
A Neuronal Basis for the Osteocalcin Regulation of Bone Mass
骨钙素调节骨量的神经元基础
- 批准号:
9764336 - 财政年份:2018
- 资助金额:
$ 4.22万 - 项目类别:
A Neuronal Basis for the Osteocalcin Regulation of Bone Mass
骨钙素调节骨量的神经元基础
- 批准号:
9979842 - 财政年份:2018
- 资助金额:
$ 4.22万 - 项目类别:
Elucidation of the molecular mechanism of the bone matrix protein osteocalcin in protecting brain function
阐明骨基质蛋白骨钙素保护脑功能的分子机制
- 批准号:
18K09510 - 财政年份:2018
- 资助金额:
$ 4.22万 - 项目类别:
Grant-in-Aid for Scientific Research (C)